Clinical and epidemiological characteristics associated with unfavorable tuberculosis treatment outcomes in TB-HIV co-infected patients in Brazil: a hierarchical polytomous analysis

被引:29
|
作者
do Prado, Thiago Nascimento [1 ,2 ,3 ]
Rajan, Jayant V. [4 ]
Miranda, Angelica Espinosa [3 ]
Dias, Elias dos Santos [2 ]
Cosme, Lorrayne Beliqui [1 ,2 ]
Possuelo, Lia Goncalves [5 ]
Sanchez, Mauro N. [6 ,7 ]
Golub, Jonathan E. [8 ]
Riley, Lee W. [9 ]
Maciel, Ethel Leonor [1 ,2 ,3 ]
机构
[1] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil
[2] Univ Fed Espirito Santo, Dept Enfermagem, Vitoria, ES, Brazil
[3] Univ Fed Espirito Santo, Programa Posgrad Doencas Infecciosas, Vitoria, ES, Brazil
[4] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[5] Univ Santa Cruz do Sul, Programa Posgrad Promocao Saude, Santa Cruz Do Sul, RS, Brazil
[6] Univ Brasilia, Dept Saude Publ, Brasilia, DF, Brazil
[7] Int Union TB & Lung Dis, Paris, France
[8] Univ Baltimore, Johns Hopkins Sch Med, Ctr TB Res, Baltimore, MD 21201 USA
[9] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA
基金
美国国家卫生研究院;
关键词
Tuberculosis; HIV; Coinfection; Logistic regression; TRENDS;
D O I
10.1016/j.bjid.2016.11.006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: TB patients co-infected with HIV have worse treatment outcomes than noncoinfected patients. How clinical characteristics of TB and socioeconomic characteristics influence these outcomes is poorly understood. Here, we use polytomous regression analysis to identify clinical and epidemiological characteristics associated with unfavorable treatment outcomes among TB-HIV co-infected patients in Brazil. Methods: TB-HIV cases reported in the Brazilian information system (SINAN) between January 1, 2001 and December 31, 2011 were identified and categorized by TB treatment outcome (cure, default, death, and development of MDR TB). We modeled treatment outcome as a function of clinical characteristics of TB and patient socioeconomic characteristics by polytomous regression analysis. For each treatment outcome, we used cure as the reference outcome. Results: Between 2001 and 2011, 990,017 cases of TB were reported in SINAN, of which 93,147 (9.4%) were HIV co-infected. Patients aged 15-19 (OR= 2.86; 95% CI: 2.09-3.91) and 20-39 years old (OR= 2.30; 95% CI: 1.81-2.92) were more likely to default on TB treatment than those aged 0-14 years old. In contrast, patients aged >= 60 years were more likely to die from TB (OR = 2.22; 95% CI: 1.43-3.44) or other causes (OR= 2.86; 95% CI: 2.14-3.83). Black patients were more likely to default on TB treatment (OR= 1.33; 95% CI: 1.22-1.44) and die from TB (OR= 1.50; 95% CI: 1.29-1.74). Finally, alcoholism was associated with all unfavorable outcomes: default (OR= 1.94; 95% CI: 1.73-2.17), death due to TB (OR= 1.46; 95% CI: 1.25-1.71), death due to other causes (OR= 1.38; 95% CI: 1.21-1.57) and MDR-TB (OR = 2.29; 95% CI: 1.46-3.58). Conclusions: Socio-economic vulnerability has a significant effect on treatment outcomes among TB-HIV co-infected patients in Brazil. Enhancing social support, incorporation of alcohol abuse screening and counseling into current TB surveillance programs and targeting interventions to specific age groups are interventions that could improve treatment outcomes. (C) 2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND license.
引用
收藏
页码:162 / 170
页数:9
相关论文
共 50 条
  • [1] Diagnosis & treatment of tuberculosis in HIV co-infected patients
    Padmapriyadarsini, C.
    Narendran, G.
    Swaminathan, Soumya
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2011, 134 (06) : 850 - 865
  • [2] Tuberculosis treatment outcomes of diabetic and non-diabetic TB/HIV co-infected patients: A nationwide observational study in Brazil
    Villalva-Serra, Klauss
    Barreto-Duarte, Beatriz
    Nunes, Vanessa M.
    Menezes, Rodrigo C.
    Rodrigues, Moreno M. S.
    Queiroz, Artur T. L.
    Arriaga, Maria B.
    Cordeiro-Santos, Marcelo
    Kritski, Afranio L.
    Sterling, Timothy R.
    Araujo-Pereira, Mariana
    Andrade, Bruno B.
    FRONTIERS IN MEDICINE, 2022, 9
  • [3] Analysis of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in HIV/TB Co-infected Patients During HAART
    Yang Zhou
    Hui Wang
    Sha-xi Li
    Gui-lin Yang
    Ying-xia Liu
    InfectionInternational(ElectronicEdition), 2014, 3 (03) : 122 - 128
  • [4] Tuberculosis treatment default among HIV-TB co-infected patients in urban Uganda
    Elbireer, Sawsan
    Guwatudde, David
    Mudiope, Peter
    Nabbuye-Sekandi, Juliet
    Manabe, Yukari C.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 (08) : 981 - 987
  • [5] Incidence of tuberculosis and immunological profile of TB/HIV co-infected patients in Nigeria
    Musa, Baba Maiyaki
    Musa, Babashani
    Muhammed, Hamza
    Ibrahim, Nashabaru
    Musa, Abubakar Garbati
    ANNALS OF THORACIC MEDICINE, 2015, 10 (03) : 185 - 192
  • [6] Clinicodemographic profile and outcome of tuberculosis treatment in TB-HIV co-infected patients receiving daily ATT under a single window TB/HIV services delivery initiative
    Maji, Debapriya
    Agarwal, Upasna
    Kumar, Lokender
    Vinay, V.
    Sharma, Amit
    MONALDI ARCHIVES FOR CHEST DISEASE, 2023, 93 (03)
  • [7] Socio-Demographic Profile and Prevalence of Tuberculosis (TB) Treatment Outcomes among Tuberculosis/Human Immunodeficiency Virus (TB/HIV) Co-Infected Patients in Kelantan
    Nor, Siti Romaino Mohd
    Husin, Mohd Rozi
    Jaeb, Mat Zuki Mat
    Naing, Nyi Nyi
    PERTANIKA JOURNAL OF SCIENCE AND TECHNOLOGY, 2021, 29 (04): : 2279 - 2293
  • [8] Abandonment of tuberculosis treatment among patinets co-infected with TB/HIV
    Ataide Rodrigues, Ivaneide Leal
    Monteiro, Larissa Lima
    Barros Pacheco, Regia Hevelline
    Dias da Silva, Silvio Eder
    REVISTA DA ESCOLA DE ENFERMAGEM DA USP, 2010, 44 (02) : 380 - 384
  • [9] The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis
    Tanuja N. Gengiah
    Nicholas H. G. Holford
    Julia H. Botha
    Andrew L. Gray
    Kogieleum Naidoo
    Salim S. Abdool Karim
    European Journal of Clinical Pharmacology, 2012, 68 : 689 - 695
  • [10] The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis
    Gengiah, Tanuja N.
    Holford, Nicholas H. G.
    Botha, Julia H.
    Gray, Andrew L.
    Naidoo, Kogieleum
    Karim, Salim S. Abdool
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (05) : 689 - 695